Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. Operating Income 2012–2025
Coherus Biosciences Inc. annual/quarterly operating income history and growth rate from 2012 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Coherus Biosciences Inc. operating income for the quarter ending March 31, 2026 was -36.2 M, a 20.43% decrease year-over-year.
- Coherus Biosciences Inc. operating income for the twelve months ending March 31, 2026 was -171.4 M, a 7.98% decrease year-over-year.
- Coherus Biosciences Inc. annual operating income for 2025 was -181.1 M, a 9.28% decrease from 2024.
- Coherus Biosciences Inc. annual operating income for 2024 was -199.7 M, a 1.75% decrease from 2023.
- Coherus Biosciences Inc. annual operating income for 2023 was -203.2 M, a 20.90% decrease from 2022.
- Coherus Biosciences Inc. annual operating income for 2022 was -256.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Coherus Biosciences Inc. Operating Income — FAQ
Coherus Biosciences Inc. (CHRS) operating income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Coherus Biosciences Inc.'s operating income?
Coherus Biosciences Inc. (CHRS) reported operating income of -$181M for fiscal 2025.
Where can I see CHRS's operating income history?
The chart and table above show Coherus Biosciences Inc.'s operating income by year and by quarter, including the growth rate.